Price Alert

U.S. Physical Therapy Inc... (USPH)

NYSE: USPH · Real-Time Price · USD

85.14

-0.84 (-0.98%)

At close: Aug 15, 2025, 12:25 PM

U.S. Physical Therapy Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	164.18M	152.55M	180.45M	168.03M	167.19M	155.68M	154.8M	150.01M	151.49M	148.51M	141.18M	139.6M	140.66M	131.7M	129.83M	125.89M	126.93M	112.37M
Cost of Revenue	122.56M	121.48M	146.75M	138.9M	136.13M	125.65M	126.83M	122.08M	119.28M	117.65M	113.35M	112.82M	109.83M	105.12M	102.65M	96.09M	92.62M	86.47M
Gross Profit	41.62M	31.07M	33.7M	29.13M	31.07M	30.03M	27.98M	27.93M	32.21M	30.86M	27.83M	26.78M	30.82M	26.59M	27.18M	29.8M	34.3M	25.9M
Operating Income	24.94M	19.64M	14.54M	14.75M	19.61M	14.32M	16.61M	15.88M	20.06M	17M	16.17M	14.89M	20.08M	15.03M	-16.46M	16.93M	22.23M	15.02M
Interest Income	28K	24K	306K	1.02M	1.07M	1.54M	1.58M	1.67M	517K	64K	69K	n/a	679K	46K	41K	58K	46K	54K
Pretax Income	22.65M	17.33M	18.32M	12.34M	14.79M	14.76M	106K	15.78M	19.09M	14.4M	4.56M	16.04M	19.5M	15.48M	18.39M	17.94M	22.04M	14.83M
Net Income	8.81M	9.9M	7.44M	5.53M	6.88M	6.61M	-5.73M	7.01M	8.05M	11.43M	2.61M	9.41M	11.35M	11.98M	9.38M	8.47M	10.54M	903K
Selling & General & Admin	n/a	16.25M	15.57M	14.38M	11.45M	15.71M	11.36M	9.61M	12.14M	13.86M	11.93M	11.89M	10.74M	11.56M	10.72M	12.87M	12.07M	10.87M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	16.69M	-4.82M	3.59M	n/a	109K	62K	85K	78K	n/a	-467K	n/a	65K	n/a	n/a	-4.6M	n/a	n/a	n/a
Operating Expenses	16.69M	11.42M	19.16M	14.38M	11.45M	15.71M	11.36M	12.05M	12.14M	13.39M	11.93M	11.89M	10.74M	11.56M	6.12M	12.87M	12.07M	10.87M
Interest Expense	2.42M	2.28M	2.05M	2.02M	1.98M	1.97M	2.01M	2.1M	2.63M	2.56M	2.24M	2.01M	987K	540K	191K	268K	237K	246K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	1.63M	-2.54M	-2.44M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	139.25M	132.91M	165.91M	153.29M	147.58M	141.36M	138.19M	134.13M	131.42M	131.04M	125.28M	124.71M	120.58M	116.67M	108.77M	108.96M	104.7M	97.35M
Income Tax Expense	4.93M	3.86M	5.83M	2.56M	3.08M	3.14M	1.4M	3.56M	4.23M	2.97M	1.21M	3.21M	4.24M	3.5M	3.95M	3.81M	4.57M	2.94M
Shares Outstanding (Basic)	15.2M	15.13M	15.06M	15.08M	15.07M	15.02M	14.99M	14.99M	13.72M	13.03M	13M	13M	13M	12.94M	12.91M	12.91M	12.9M	12.87M
Shares Outstanding (Diluted)	15.2M	15.13M	15.06M	15.08M	15.07M	15.02M	14.99M	14.99M	13.72M	13.03M	13M	13M	13M	12.94M	12.91M	12.91M	12.9M	12.87M
EPS (Basic)	0.58	0.80	0.52	0.39	0.47	0.46	-0.38	0.51	0.64	0.88	0.20	0.72	0.87	0.93	0.73	0.66	0.82	0.07
EPS (Diluted)	0.58	0.80	0.52	0.39	0.47	0.46	-0.38	0.51	0.64	0.88	0.20	0.72	0.87	0.93	0.73	0.66	0.82	0.07
EBITDA	31.13M	25.47M	26.06M	18.74M	21.29M	20.82M	6.23M	21.85M	25.55M	20.74M	10.59M	21.7M	23.96M	19.84M	21.65M	21.24M	25.08M	17.76M
EBIT	25.07M	19.61M	20.37M	14.35M	16.77M	16.72M	2.12M	17.88M	21.73M	16.96M	6.8M	18.05M	20.48M	16.02M	18.58M	18.21M	22.28M	15.08M
Depreciation & Amortization	6.06M	5.87M	5.68M	4.39M	4.51M	4.09M	4.11M	3.97M	3.83M	3.79M	3.79M	3.65M	3.47M	3.82M	3.07M	3.04M	2.8M	2.68M